Skip to main content
Laura Alonso, MD, Endocrinology, New York, NY

Laura Cristina Alonso MD

Diabetes, Lipid Metabolism, Obesity


Chief, Division of Endocrinology, Diabetes and Metabolism, Weill Cornell Medicine

Request Appointment
  • 1305 York Avenue4th FloorNew York, NY 10021

  • Book by Phone+1(419) 894-3264

Overview of  Dr. Alonso

Dr. Laura Alonso is an endocrinologist based in New York, NY, specializing in diabetes, lipid metabolism, and obesity. She completed her fellowship in Endocrinology, Diabetes, and Metabolism at the University of Chicago and previously served as an Associate Professor at UMass Memorial Medical Group. Her research focuses on diabetes mellitus, insulin resistance, blood glucose, cell proliferation, and glucose, with several publications in esteemed journals. Notable recognitions include being an Elected Member of the American Society for Clinical Investigation in 2019 and receiving CMS Meaningful Use Stage Certifications from Allscripts.

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Endocrinology, Diabetes, and Metabolism, 2000 - 2002
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 1998 - 2000
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1997

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2019 - 2026
  • MA State Medical License
    MA State Medical License 2013 - 2021
  • PA State Medical License
    PA State Medical License 2005 - 2014
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Elected Member American Society for Clinical Investigation, 2019
  • CMS Meaningful Use Stage 2 Certification Allscripts Enterprise EHR, Allscripts, 2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2014, 2016-2017

Publications & Presentations

PubMed

Lectures

  • Hormone Signaling in the Islet: New Concepts 
    ENDO 2019 - New Orleans, LA - 3/24/2019

Press Mentions

  • Is Type 1 Diabetes Genetic?
    Is Type 1 Diabetes Genetic?February 4th, 2022
  • COVID May Trigger Hyperglycemia by Harming Fat Cells
    COVID May Trigger Hyperglycemia by Harming Fat CellsOctober 4th, 2021
  • COVID-19 May Trigger Hyperglycemia and Worsen Disease by Harming Fat Cells
    COVID-19 May Trigger Hyperglycemia and Worsen Disease by Harming Fat CellsOctober 1st, 2021

Grant Support

  • GIP receptor signaling mechanismsWEILL MEDICAL COLL OF CORNELL UNIV2026–2031
  • Research Training in Endocrinology and MetabolismWEILL MEDICAL COLL OF CORNELL UNIV2023–2028
  • Benefits and harms of activating ATF6 in beta cellsWEILL MEDICAL COLL OF CORNELL UNIV2023–2026
  • Role of Polyamines and Hypusine in Nutrient-Induced Beta-Cell Growth and ReplicationUNIVERSITY OF CHICAGO2020–2025
  • Free Fatty Acids, P16 And Pancreatic Beta Cell ProliferationNational Institute Of Diabetes And Digestive And Kidney Diseases2012

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    Anthem Blue Access PPO
    Anthem Blue Preferred HMO
    BCBS Blue Card PPO
    BCBS Illinois PPO
    Great West PPO
    HealthAmerica HealthAssurance PPO
    Highmark BCBS ClassicBlue
    Highmark BCBS PPOBlue
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: